PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Kidney Research and Clinical Practice10.23876/j.krcp.2018.37.1.98201837198-99Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68–78]Ran-hui Cha, Shin Wook Kang, Cheol Whee Park, Dae Ryong Cha, Ki Young Na, Sung Gyun Kim, Sun Ae Yoon, Sejoong Kim, Sang Youb Han, Jung Hwan Park, Jae Hyun Chang, Chun Soo Lim, Yon Su Kimhttp://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-01-15.pdf, http://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-01-15.pdf
Kidney Research and Clinical Practice10.23876/j.krcp.2017.36.1.68201736168-78Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in KoreaRan-hui Cha, Shin Wook Kang, Cheol Whee Park, Dae Ryong Cha, Ki Young Na, Sung Gyun Kim, Sun Ae Yoon, Sejoong Kim, Sang Youb Han, Jung Hwan Park, Jae Hyun Chang, Chun Soo Lim, Yon Su Kimhttp://pdf.medrang.co.kr/KRCP2/2017/036/KRCP036-01-09.pdf, http://pdf.medrang.co.kr/KRCP2/2017/036/KRCP036-01-09.pdf
Renal Failure10.1080/0886022x.2018.1561376201941147-56Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patientsMayumi Asai, Sei Kumakura, Mami Kikuchihttps://tandfonline.com/doi/pdf/10.1080/0886022X.2018.1561376, https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2018.1561376
Journal of Renal Care10.1111/j.1755-6686.2010.00167.x20103668-75SCREENING FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASERajan Sharmahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-6686.2010.00167.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-6686.2010.00167.x/fullpdf
Transplant Infectious Disease10.1034/j.1399-3062.1999.010408.x199914288-294Renal dysfunction and hyperglycemia in a renal transplant recipientB. Leventhal, R. Soave, J. Mouradian, J.S. Cheighhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1399-3062.1999.010408.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1399-3062.1999.010408.x, http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1399-3062.1999.010408.x/fullpdf
Journal of Renal Care10.1111/j.1755-6686.2010.00160.x201036136-145CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTSEmily P. McQuarrie, Bengt C. Fellström, Hallvard Holdaas, Alan G. Jardinehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-6686.2010.00160.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-6686.2010.00160.x/fullpdf
Journal of Renal Nutrition10.1053/j.jrn.2016.08.0042016266373-379Prevalence of Chronic Kidney Disease in Turkish Adults With Obesity and Metabolic Syndrome: A Post Hoc Analysis from Chronic Renal Disease in Turkey StudyTurgay Arinsoy, Serpil Muge Deger, Kenan Ates, Bulent Altun, Tevfik Ecder, Taner Camsari, Kamil Serdengecti, Gultekin Suleymanlarhttps://api.elsevier.com/content/article/PII:S1051227616300826?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1051227616300826?httpAccept=text/plain
Cardiovascular Therapeutics10.1111/j.1755-5922.2010.00217.x2010294280-284Fenoldopam in Critically Ill Patients with Early Renal Dysfunction. A Crossover StudyMiguel Cobas, Gian Paparcuri, Maria De La Pena, Gaston Cudemus, Erik Barquist, Albert Varonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-5922.2010.00217.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2010.00217.x/fullpdf
Advances in Renal Replacement Therapy10.1053/j.arrt.2003.10.006200411114-23Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failureAntonio Alberto Lopeshttps://api.elsevier.com/content/article/PII:S1073444903000657?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1073444903000657?httpAccept=text/plain
European Heart Journal10.1093/ehjci/ehaa946.3352202041Supplement_2Impact of polyvascular disease and renal dysfunction on cardiovascular outcomes in diabetes: post hoc analyses from EMPA-REG OUTCOMES Verma, C.D Mazer, S.E Inzucchi, C Wanner, A.P Ofstad, O.E Johansen, I Zwiener, J.T George, J Butler, B Zinmanhttp://academic.oup.com/eurheartj/article-pdf/41/Supplement_2/ehaa946.3352/34519933/ehaa946.3352.pdf, http://academic.oup.com/eurheartj/article-pdf/41/Supplement_2/ehaa946.3352/34519933/ehaa946.3352.pdf